Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access Cohort-Reference-Cited by-同舟云学术

Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access Cohort

Published:2017-05-01 Issue:1 Volume:75 Page:97-107
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Lacombe Karine,Fontaine Hélène,Dhiver Catherine,Metivier Sophie,Rosenthal Eric,Antonini Teresa,Valantin Marc Antoine,Miailhes Patrick,Harent Stanislas,Batisse Dominique,Pageaux Georges-Philippe,Chas Julie,Aumaitre Hugues,Dominguez Stephanie,Allegre Thierry,Lafeuillade Alain,Billaud Eric,De Truchis Pierre,Perre Philippe,Leroy Vincent,De Ledinghen Victor,Sogni Philippe,Dabis François,Zhao Yue,Filipovics Anne,Fedchuk Larysa,Akremi Raoudha,Bennai Yacia,Salmon Ceron Dominique

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference38 articles.

1. Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis;Platt;Lancet Infect Dis.,2016

2. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS clinical trials group;Sherman;Clin Infect Dis.,2002

3. Burden of HIV and hepatitis C co-infection: the changing epidemiology of hepatitis C in HIV-infected patients in France;Cacoub;Liver Int.,2015

4. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis;Graham;Clin Infect Dis.,2001

5. Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis;Thein;AIDS,2008

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opportunities and challenges for the application of artificial intelligence paradigms into the management of endemic viral infections: The example of Chronic Hepatitis C Virus;Reviews in Medical Virology;2024-02-02

2. Serial changes in renal indices in chronic HCV patients with and without HIV co-infection receiving sofosbuvir and tenofovir-based therapies;Transactions of The Royal Society of Tropical Medicine and Hygiene;2022-11-18

3. Daclatasvir as a hepatitis C infection treatment option: an up-to-date evaluation;Expert Opinion on Pharmacotherapy;2022-11-17

4. Risk of HIV viral rebound in HIV infected patients on direct acting antivirals (DAAs) treatment for HCV;PLOS ONE;2022-02-03

5. Effects of direct-acting antiviral treatment on reducing mortality among Medicare beneficiaries with HIV and HCV coinfection;AIDS Care;2021-09-28